Abbreviated Clinical Report About Israeli Study Completed

On Oct 14, 2010, Rick Doblin, Ph.D., met in Tel Aviv, Israel, with Moshe Kotler, M.D., Principle Investigator of MAPS’ Israeli MDMA/PTSD study. They discussed the abbreviated clinical report of the results of the first five subjects, and the design of a new protocol. Dr. Kotler and co-therapist Sergio Marchevsky, M.D., signed off on the report. It will be submitted along with our new protocol application, which is still in process, to the Israeli Ministry of Health. While in Tel Aviv and Jerusalem, Rick also met with psychologists who will become co-therapists in the new study.